One possible explanation is that the synergistic effect of elevated ET‐1, DM, and impaired kidney function may contribute to the further deterioration of coronary microcirculation, which influences adverse cardiovascular outcomes. The gene discussed is EDN1; the disease is diabetes mellitus.